Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doctive lollipop versus nystatin for denture stomatitis
RBR-5yzdx8gPhase 3Not yet recruiting
- Sponsor
- Universidade Federal de Goiás
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nystatin and methylene blue in denture stomatitis (DS) and oral candidiasis (2 arms), sponsored by Universidade Federal de Goiás. Primary endpoint: Improvement or worsening of signs and symptoms of denture stomatitis. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
nystatinmethylene blue
03
Conditions
denture stomatitis (DS)oral candidiasis
Beyond the preview
Go deeper on RBR-5yzdx8g.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5yzdx8g.